Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Cash & Equivalents (2016 - 2025)

Xtant Medical Holdings has reported Cash & Equivalents over the past 16 years, most recently at $17.1 million for Q4 2025.

  • Quarterly Cash & Equivalents rose 175.09% to $17.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $17.1 million through Dec 2025, up 175.09% year-over-year, with the annual reading at $17.1 million for FY2025, 175.09% up from the prior year.
  • Cash & Equivalents was $17.1 million for Q4 2025 at Xtant Medical Holdings, up from $10.4 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $20.3 million in Q2 2021 and troughed at $4.1 million in Q2 2023.
  • The 5-year median for Cash & Equivalents is $9.5 million (2023), against an average of $11.6 million.
  • Year-over-year, Cash & Equivalents surged 679.28% in 2021 and then crashed 74.91% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $18.2 million in 2021, then grew by 11.26% to $20.3 million in 2022, then crashed by 71.84% to $5.7 million in 2023, then grew by 8.47% to $6.2 million in 2024, then surged by 175.09% to $17.1 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Cash & Equivalents are $17.1 million (Q4 2025), $10.4 million (Q3 2025), and $6.9 million (Q2 2025).